DEA published its interim final rule on e-prescribing for controlled substances (EPCS) more than two years ago. While vendors work toward compliance, nationwide deployment of EPCS can only occur once both state and federal laws are aligned in all jurisdictions.
The Office of Inspector General has issued a report implicating more than 2,600 pharmacies in Medicare Part D fraud
Pharmacy associations offered a range of comments after the Supreme Court ruling that upheld key elements of the Affordable Care Act
CMS is assessing genetic testing for the older population
Recent changes to Medicaid's reimbursement rules raise many confusing questions. Drug Topics' senior legal columnist sets out to clarify some key points
The National Rural Health Association recently sent a letter to U.S. Rep. Cathy McMorris Rodgers (R-WA) in support of the bill she introduced in March, H.R. 4215, or "The Medicare Pharmacy Transparency and Fair Auditing Act."
Okay, pharmacists. All together now. What's the one question you hear all day long?
Because their classification is variable, the taxation of glucose test strips varies from state to state, giving rise to massive confusion and loss of revenue
Ned Milenkovich has been reappointed to the Illinois State Board of Pharmacy for an additional five-year term
NABP has launched an initiative to transfer prescription monitoring program information across state lines
Connecticut's recently enacted law legalizing medical marijuana includes language ensuring that pharmacists who follow state law will be protected from prosecution
Cardinal Health this week settled litigation with the DEA, which suspended Cardinal?s ability to sell controlled substance medications from its Lakeland, Fla., distribution center for two years.
Accreditation standards guarantee reputation and high safety standards for compounding pharmacies.
One pharmacist argues that wanting to be called Doctor is more than just ego.
Four pharmacies have sued HHS and CMS to halt what they call a violation of federal Medicare Part D statute.
Healthcare industry experts discuss the pros and cons.
Pharmacists need additional guidance on the handling of biosimilar products in the pharmacy when these products become more widely available following the approval of the biosimilar pathway, said Marcie Bough, senior director of government affairs, APhA, speaking at an FDA hearing last week.
Connecticut's legislature passed a bill this weekend that would legalize the use of medical marijuana in the state. While several other states have similar laws, Connecticut is putting more restrictions on the dispensing of the drug.
The National Community Pharmacists Association and the National Association of Chain Drug Stores expressed their support and made recommendations for Congress's reauthorization of the Prescription Drug User Fee Act.
Several U.S. senators and representatives are speaking at the National Community Pharmacists Association's annual Legislative Conference, which will be held May 7-9 in Washington, D.C.
Compliance with environmental laws and regulations pertaining to pharmaceutical waste disposal is an essential part of pharmacy management. Here are some tips to make the process less daunting.
The recent passage of a Kentucky bill prohibiting pharmacy benefit managers from recouping payments through pharmacy audits when there is no evidence of fraud bodes well for similar federal legislation, according to a recent statement from the National Association of Chain Drug Stores.
CMS's proposed regulation for long-term care consultant pharmacists is stirring up controversy.
Continuing legal battles between the Drug Enforcement Administration and Cardinal Health have raised questions about federal drug policy and the role of distributors.
Federal marshals seized more than 1,600 containers from a Missouri distributor last week, alleging that the drugs were unapproved by FDA and misbranded.
The Federal Trade Commission (FTC) approved the $29.1 billion merger of Express Scripts and Medco Health Solutions on Monday, but the retail pharmacy industry continues to fight the deal, vowing to push a request for a temporary restraining order (TRO) that it filed on Friday.
The National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association, and 9 retail pharmacy companies filed a lawsuit Thursday to stop the proposed merger of pharmacy benefit manager giants Express Scripts and Medco Health Solutions.
ASHP continues to make solving the drug shortages problem a top priority.
Implementation of the "biosimilars" law is going well, but the exclusivity period seems to be a problem.
Occasionally mergers receive the attention of Congress, especially when consumer welfare and jobs are at stake. A prime example: The proposed merger of Express Scripts and Medco Health Solutions.
